These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 16280053)

  • 1. Mutation analysis of FANCD2, BRIP1/BACH1, LMO4 and SFN in familial breast cancer.
    Lewis AG; Flanagan J; Marsh A; Pupo GM; Mann G; Spurdle AB; Lindeman GJ; Visvader JE; Brown MA; Chenevix-Trench G;
    Breast Cancer Res; 2005; 7(6):R1005-16. PubMed ID: 16280053
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutation analysis of BRIP1/BACH1 in BRCA1/BRCA2 negative Chinese women with early onset breast cancer or affected relatives.
    Cao AY; Huang J; Hu Z; Li WF; Ma ZL; Tang LL; Zhang B; Su FX; Zhou J; Di GH; Shen KW; Wu J; Lu JS; Luo JM; Yuan WT; Shen ZZ; Huang W; Shao ZM
    Breast Cancer Res Treat; 2009 May; 115(1):51-5. PubMed ID: 18483852
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutational analysis of the BRCA1-interacting genes ZNF350/ZBRK1 and BRIP1/BACH1 among BRCA1 and BRCA2-negative probands from breast-ovarian cancer families and among early-onset breast cancer cases and reference individuals.
    Rutter JL; Smith AM; Dávila MR; Sigurdson AJ; Giusti RM; Pineda MA; Doody MM; Tucker MA; Greene MH; Zhang J; Struewing JP
    Hum Mutat; 2003 Aug; 22(2):121-8. PubMed ID: 12872252
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of Fanconi Anemia genes in familial breast cancer predisposition.
    Seal S; Barfoot R; Jayatilake H; Smith P; Renwick A; Bascombe L; McGuffog L; Evans DG; Eccles D; Easton DF; Stratton MR; Rahman N;
    Cancer Res; 2003 Dec; 63(24):8596-9. PubMed ID: 14695169
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BRIP1 (BACH1) variants and familial breast cancer risk: a case-control study.
    Frank B; Hemminki K; Meindl A; Wappenschmidt B; Sutter C; Kiechle M; Bugert P; Schmutzler RK; Bartram CR; Burwinkel B
    BMC Cancer; 2007 May; 7():83. PubMed ID: 17504528
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutation analysis and characterization of ATR sequence variants in breast cancer cases from high-risk French Canadian breast/ovarian cancer families.
    Durocher F; Labrie Y; Soucy P; Sinilnikova O; Labuda D; Bessette P; Chiquette J; Laframboise R; Lépine J; Lespérance B; Ouellette G; Pichette R; Plante M; Tavtigian SV; Simard J
    BMC Cancer; 2006 Sep; 6():230. PubMed ID: 17010193
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The frequency of germ-line mutations in the breast cancer predisposition genes BRCA1 and BRCA2 in familial prostate cancer. The Cancer Research Campaign/British Prostate Group United Kingdom Familial Prostate Cancer Study Collaborators.
    Gayther SA; de Foy KA; Harrington P; Pharoah P; Dunsmuir WD; Edwards SM; Gillett C; Ardern-Jones A; Dearnaley DP; Easton DF; Ford D; Shearer RJ; Kirby RS; Dowe AL; Kelly J; Stratton MR; Ponder BA; Barnes D; Eeles RA
    Cancer Res; 2000 Aug; 60(16):4513-8. PubMed ID: 10969800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lack of large genomic deletions in BRIP1, PALB2, and FANCD2 genes in BRCA1/2 negative familial breast cancer.
    Ameziane N; van den Ouweland AM; Adank MA; Vijzelaar RN; Errami A; Dorsman JC; Joenje H; Meijers-Heijboer H; Waisfisz Q
    Breast Cancer Res Treat; 2009 Dec; 118(3):651-3. PubMed ID: 19504183
    [No Abstract]   [Full Text] [Related]  

  • 9. No germline mutations in the histone acetyltransferase gene EP300 in BRCA1 and BRCA2 negative families with breast cancer and gastric, pancreatic, or colorectal cancer.
    Campbell IG; Choong D; Chenevix-Trench G;
    Breast Cancer Res; 2004; 6(4):R366-71. PubMed ID: 15217503
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutation analysis of BRIP1 in male breast cancer cases: a population-based study in Central Italy.
    Silvestri V; Rizzolo P; Falchetti M; Zanna I; Masala G; Bianchi S; Palli D; Ottini L
    Breast Cancer Res Treat; 2011 Apr; 126(2):539-43. PubMed ID: 21165771
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BRCA1 germline mutations in Indian familial breast cancer.
    Valarmathi MT; A A; Deo SS; Shukla NK; Das SN
    Hum Mutat; 2003 Jan; 21(1):98-9. PubMed ID: 12497638
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BRCA2 germline mutations in Swedish breast cancer families.
    Chen J; Hedman MZ; Arver BW; Sigurdsson S; Eyfjörd JE; Lindblom A
    Eur J Hum Genet; 1998; 6(2):134-9. PubMed ID: 9781057
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Mutational analysis of BRCA1 and BRCA2 genes in early-onset breast cancer patients in Shanghai].
    Song CG; Hu Z; Yuan WT; Di GH; Shen ZZ; Huang W; Shao ZM
    Zhonghua Yi Xue Za Zhi; 2005 Nov; 85(43):3030-4. PubMed ID: 16324400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytogenetic instability in ovarian epithelial cells from women at risk of ovarian cancer.
    Pejovic T; Yates JE; Liu HY; Hays LE; Akkari Y; Torimaru Y; Keeble W; Rathbun RK; Rodgers WH; Bale AE; Ameziane N; Zwaan CM; Errami A; Thuillier P; Cappuccini F; Olson SB; Cain JM; Bagby GC
    Cancer Res; 2006 Sep; 66(18):9017-25. PubMed ID: 16982743
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BRCA2 germline mutations in Cypriot patients with familial breast/ovarian cancer.
    Hadjisavvas A; Charalambous E; Adamou A; Christodoulou CG; Kyriacou K
    Hum Mutat; 2003 Feb; 21(2):171. PubMed ID: 12552570
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BRIP1, PALB2, and RAD51C mutation analysis reveals their relative importance as genetic susceptibility factors for breast cancer.
    Wong MW; Nordfors C; Mossman D; Pecenpetelovska G; Avery-Kiejda KA; Talseth-Palmer B; Bowden NA; Scott RJ
    Breast Cancer Res Treat; 2011 Jun; 127(3):853-9. PubMed ID: 21409391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BRCA1 mutations and polymorphisms in a hospital-based consecutive series of breast cancer patients from Apulia, Italy.
    Tommasi S; Crapolicchio A; Lacalamita R; Bruno M; Monaco A; Petroni S; Schittulli F; Longo S; Digennaro M; Calistri D; Mangia A; Paradiso A
    Mutat Res; 2005 Oct; 578(1-2):395-405. PubMed ID: 16026807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FANCD2 associated with sporadic breast cancer risk.
    Barroso E; Milne RL; Fernández LP; Zamora P; Arias JI; Benítez J; Ribas G
    Carcinogenesis; 2006 Sep; 27(9):1930-7. PubMed ID: 16679306
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A screen for germline mutations in the gene encoding CCCTC-binding factor (CTCF) in familial non-BRCA1/BRCA2 breast cancer.
    Zhou XL; Werelius B; Lindblom A
    Breast Cancer Res; 2004; 6(3):R187-90. PubMed ID: 15084242
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of FANCB and FANCN/PALB2 fanconi anemia genes in BRCA1/2-negative Spanish breast cancer families.
    García MJ; Fernández V; Osorio A; Barroso A; Llort G; Lázaro C; Blanco I; Caldés T; de la Hoya M; Ramón Y Cajal T; Alonso C; Tejada MI; San Román C; Robles-Díaz L; Urioste M; Benítez J
    Breast Cancer Res Treat; 2009 Feb; 113(3):545-51. PubMed ID: 18302019
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.